You can find it here on the California Stem Cell Report with the links below to recent items growing out of a state legislative hearing.
CEO Millan Makes the Case for California's $3 Billion Stem Cell Research Program
The top executive at California $3 billion stem cell agency, which expects to run out of cash for new awards next year, outlined for state lawmakers last week the benefits of the nearly 14-year-old program.
California Stem Cell Agency Touts its Economic Impact on the Golden State
The California stem cell agency last week told its story to a state Assembly committee on biotechnology, including economic figures from a study financed by the agency itself.
'Better Than Hope' -- An Advocate's View of California's $3 Billion Stem Cell Research Program
A Before and After Story of $138 Million in California Stem Cell Cash
The head of the stem cell program at UC Davis says California is leading the way into a "new era of living medicine," thanks to the efforts of the $3 billion state stem cell agency.
A father from Folsom, Ca., earlier this month told a state legislative committee about how his baby boy was saved through a clinical trial that was being financed by the Golden State's $3 billion stem cell agency.
A committee of the California Legislature today examined the state's $3 billion stem cell agency. Officials of the agency and others presented their perspective. Here is the text of prepared remarks by David Jensen, publisher of this blog, who appeared at the invitation of the Legislature. This is a third-party overview that deals with pluses, minuses and policy questions.
California's $3 billion stem cell experiment received a host of accolades last week at a state legislative hearing, but one strong, critical voice was not heard in the proceedings.
No comments:
Post a Comment